Renrui Y. Zou
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.
PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: July 23, 2026
Targeting PAK1 suppresses tumor progression by promoting mRNA decay of oncogenic factors and enhancing chemotherapeutic efficacy in colorectal cancer.
Journal: Genes & diseases
Published: June 26, 2024
The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
Journal: Cancer biomarkers : section A of Disease markers
Published: November 26, 2023
Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: August 03, 2023
SAA suppresses α-PD-1 induced anti-tumor immunity by driving TH2 polarization in lung adenocarcinoma.
Journal: Cell death & disease
Published: May 22, 2023
CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer.
Journal: Cell death & disease
Published: February 11, 2023
Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology.
Journal: Frontiers in cell and developmental biology
Published: January 28, 2022
NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase pi.
Journal: Cancer medicine
Published: December 15, 2021
Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer.
Journal: Frontiers in oncology
Published: October 07, 2021
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.
Journal: Journal of cellular and molecular medicine
Published: March 23, 2021
Last Updated: 09/26/2026